Latest On Avalon GloboCare Corp (AVCO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-11-09 02:49 EST | News | Avalon GloboCare to acquire a 60% interest in Laboratory Services MSO, LLC | N/A |  |
| 2022-04-27 19:05 EST | News | Avalon GloboCare stock gains after expanding IP portfolio with 16 new patent applications | N/A | |
| 2021-07-20 20:47 EST | News | Avalon Globocare to acquire SenlangBio in all-stock deal | N/A | |
| 2021-03-30 02:30 EST | News | Avalon inks collaboration deal with University of Pittsburgh Medical Center | N/A | |
| 2021-01-02 15:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-13 03:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-15 11:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 11:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-01 17:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-22 17:17 EST | News | Avalon GloboCare and Adial Pharma rallies on strategic collaboration | N/A | |
| 2020-10-02 14:28 EST | News | Avalon GloboCare to add NHL patients to lead CAR T study | N/A | |
| 2020-09-26 04:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-20 11:44 EST | News | Avalon GloboCare up 16% on COVID-19 test deal | N/A | |
| 2020-08-09 08:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 00:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 12:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 16:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-29 17:58 EST | News | Avalon GloboCare's CAR-T therapy completes early-stage study in B-cell malignancies | N/A | |
| 2020-06-26 11:09 EST | News | Avalon GloboCare +7% on partnership with University of Natural Resources and Life Sciences | N/A | |
| 2020-06-08 13:58 EST | News | Avalon Globocare inks deal for COVID-19 tests | N/A | |
| 2020-05-31 16:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-20 12:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-03 08:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-08 20:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-07 00:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-06 23:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-29 23:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 03:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-07 23:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-29 23:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-16 23:12 EST | Financials | Company financials have been released. | Neutral | |
| 2019-12-16 23:09 EST | Financials | Company financials have been released. | Neutral | |
| 2019-12-13 11:51 EST | News | Sarepta Therapeutics leads healthcare gainers; OncoSec Medical among losers | N/A | |
| 2019-12-12 11:45 EST | News | Amneal Pharmaceuticals leads healthcare gainers; Bellicum Pharmaceuticals among losers | N/A | |
| 2019-11-27 23:09 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-26 23:10 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-22 23:07 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-15 23:08 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-14 12:08 EST | News | Avalon: Fortressing Capital Structure And Strengthening Fundamentals | N/A | |
| 2019-11-06 23:09 EST | Financials | Company financials have been released. | Neutral | |
| 2019-10-21 10:19 EST | News | Avalon Globocare repurchases 100% of outstanding warrants | N/A | |
| 2019-09-05 22:48 EST | News | Avalon: Poised For Market Conquest | N/A | |
| 2019-06-30 01:05 EST | Financials | Company financials have been released. | Neutral | |
| 2019-03-31 01:05 EST | Financials | Company financials have been released. | Neutral | |
| 2018-12-31 00:05 EST | Financials | Company financials have been released. | Neutral | |
| 2018-09-30 01:05 EST | Financials | Company financials have been released. | Neutral | |
| 2018-06-30 01:05 EST | Financials | Company financials have been released. | Neutral | |
About Avalon GloboCare Corp (AVCO):
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. It also develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology. In addition, the company develops proprietary diagnostic and therapeutic products leveraging exosome technology; and provides development services for hospitals. The company has a strategic partnership with Weill Cornell Medical College to co-develop bio-production and standardization procedures for chimeric antigen receptor (CAR)-T Therapy; GensKey Medical Technology Co. Ltd. to co-develop and commercialize point-of-care, rapid detection antibody tests to identify whether a patient has been exposed to and has developed antibodies against SARS-CoV-2; GE Healthcare to enhance standardized automation and bio-production for cellular medicines; and HydroPeptide, LLC to co-develop and commercialize various clinical-grade, exosome-based cosmeceutical and orthopedic products, as well as research agreement with Massachusetts Institute of Technology to develop CAR technology. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey.
General
- Name Avalon GloboCare Corp
- Symbol AVCO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Care Facilities
- Full Time Employees 7
- Last Split Factor1:4
- Last Split Date2016-10-18
- Fiscal Year EndDecember
- IPO Date2016-12-06
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Providers & Services
- Web URLhttp://www.avalon-globocare.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 69
- Price/Book (Most Recent Quarter) 18.89
- Enterprise Value Revenue 73.44
View More
Financials
- Most Recent Quarter 2020-09-30
- Operating Margin -1070%
- Return on Assets -83%
- Return on Equity -259%
- Revenue 1.36 million
- Earnings Per Share -$0.19
- Revenue Per Share $0.02
- Gross Profit 284137
- Quarterly Earnings Growth -13.4%
View More
Highlights
- Market Capitalization 96.05 million
- EBITDA -13428929
- Book Value Per Share $0.07
View More
Share Statistics
- Shares Outstanding 81.4 million
- Shares Float 27.22 million
- % Held by Insiders 6573%
- % Held by Institutions 3.27%
- Shares Short 1.05 million
- Shares Short Prior Month 1.02 million
- Short Ratio 2.22
- Short % of Float 4%
- Short % of Shares Outstanding 1%
View More
Technicals
- Beta 0.49
- 52 Week High $2.19
- 52 Week Low $0.85
- 50 Day Moving Average 1.31
- 200 Day Moving Average 1.23
View More
Dividends
- Dividend Date 2016-10-18
- ExDividend Date N/A
- Dividend Yield 0%
View More
Avalon GloboCare Corp (AVCO) Dividend Calendar:
AVCO's last dividend payment was made to shareholders on October 18, 2016.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Avalon GloboCare Corp (AVCO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-09 | $N/A | -$0.04 | ||
| 2020-06-30 | 2020-09-30 | $N/A | -$0.04 | ||
| 2020-03-31 | 2020-06-30 | $296956 | -$0.04 | ||
| 2019-12-31 | 2020-03-31 | $N/A | -$0.04 | ||
| 2019-09-30 | 2019-12-31 | $383216 | -$0.07 | ||
| 2019-06-30 | 2019-09-30 | $389383 | -$0.05 | ||
| 2019-03-31 | 2019-06-30 | $271421 | -$0.06 | ||
| 2018-12-31 | 2019-03-31 | $291808 | -$0.06 | ||
| 2018-09-30 | 2018-12-31 | $413503 | -$0.04 | ||
| 2018-06-30 | 2018-09-30 | $496093 | -$0.03 | ||
| 2018-03-31 | 2018-06-30 | $307913 | -$0.02 | ||
| 2017-12-31 | 2018-03-31 | $1.44 million | -$0.02 | ||
| 2017-09-30 | 2017-12-31 | $-607945 | -$0.03 | ||
| 2017-06-30 | 2017-09-30 | $175893 | -$0.01 | ||
| 2017-03-31 | 2017-06-30 | $66286 | -$0.01 | ||
| 2016-12-31 | 2017-03-31 | $616446 | -$0.01 | ||
| 2016-09-30 | 2016-12-31 | $N/A | $-0.00 | $0.00 | |
| 2016-06-30 | 2016-09-30 | $N/A | $0.00 | $0.00 | |
| 2016-03-31 | 2016-06-30 | $N/A | $-0.00 | $0.00 | |
| 2015-12-31 | 2016-03-31 | $N/A | $-0.00 | $0.00 |
Avalon GloboCare Corp (AVCO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Avalon GloboCare Corp (AVCO) Chart:
Avalon GloboCare Corp (AVCO) News:
Below you will find a list of latest news for Avalon GloboCare Corp (AVCO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Avalon GloboCare Corp (AVCO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest AVCO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 2:21 PM EST | 32 | $0.4761 |
| Jun 13, 2022 6:33 PM EST | 100 | $0.5001 |
| Jun 13, 2022 7:13 PM EST | 9 | $0.5098 |
Avalon GloboCare Corp (AVCO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2019-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019007230/0001213900-19-007230-index.htm |
| 2019-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1630212/000121390019008592/0001213900-19-008592-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390019010155/0001213900-19-010155-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390019010273/0001213900-19-010273-index.htm |
| 2019-06-17 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1630212/000121390019010890/0001213900-19-010890-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019014752/0001213900-19-014752-index.htm |
| 2019-08-15 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1630212/000121390019015944/0001213900-19-015944-index.htm |
| 2019-08-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1630212/000121390019015968/0001213900-19-015968-index.htm |
| 2019-09-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019017131/0001213900-19-017131-index.htm |
| 2019-09-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019018998/0001213900-19-018998-index.htm |
| 2019-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019020662/0001213900-19-020662-index.htm |
| 2019-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019021392/0001213900-19-021392-index.htm |
| 2019-10-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019021623/0001213900-19-021623-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019022217/0001213900-19-022217-index.htm |
| 2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1630212/000121390019023433/0001213900-19-023433-index.htm |
| 2019-11-14 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1630212/000121390019023552/0001213900-19-023552-index.htm |
| 2019-11-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019023914/0001213900-19-023914-index.htm |
| 2019-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019025983/0001213900-19-025983-index.htm |
| 2019-12-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1630212/000121390019026164/0001213900-19-026164-index.htm |
| 2019-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019026166/0001213900-19-026166-index.htm |
| 2019-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390019026558/0001213900-19-026558-index.htm |
| 2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390020002851/0001213900-20-002851-index.htm |
| 2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390020004616/0001213900-20-004616-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390020004735/0001213900-20-004735-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390020004736/0001213900-20-004736-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390020004737/0001213900-20-004737-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390020004738/0001213900-20-004738-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390020004739/0001213900-20-004739-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390020004740/0001213900-20-004740-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390020004742/0001213900-20-004742-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390020004744/0001213900-20-004744-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390020004745/0001213900-20-004745-index.htm |
| 2020-03-30 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | https://www.sec.gov/Archives/edgar/data/1630212/000121390020008009/0001213900-20-008009-index.htm |
| 2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390020008531/0001213900-20-008531-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1630212/000121390020008536/0001213900-20-008536-index.htm |
| 2020-04-06 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1630212/000121390020008655/0001213900-20-008655-index.htm |
| 2020-04-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1630212/000121390020008664/0001213900-20-008664-index.htm |
| 2020-04-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1630212/000121390020008700/0001213900-20-008700-index.htm |
| 2020-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1630212/000121390020012325/0001213900-20-012325-index.htm |
| 2020-06-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1630212/000121390020015438/0001213900-20-015438-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390020020508/0001213900-20-020508-index.htm |
| 2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1630212/000121390020020912/0001213900-20-020912-index.htm |
| 2020-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390020022774/0001213900-20-022774-index.htm |
| 2020-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1630212/000121390020032702/0001213900-20-032702-index.htm |